Brilliant Violet 785TM anti-human CD33 [WM53] and 1 more item

The University of Virginia awarded a contract to BioLegend Inc. on June 19, 2026, for the delivery of specialized flow cytometry reagents to support laboratory research operations in Virginia. The contract encompasses two distinct monoclonal antibody products, both targeting human CD33 antigen markers: Brilliant Violet 785™ anti-human CD33 [WM53] and PE/Cyanine7 anti-human CD33 [WM53]. Both line items are to be delivered to Sajjad Dadashi Silab at the University of Virginia. The cumulative contract value is $268, with individual unit prices of $153 and $115.50 for the respective reagents.

BioLegend Inc. serves as the prime contractor under purchase order PO-0450130 for this procurement. The contract represents a straightforward procurement of laboratory reagents for research applications, with quantities of one unit each for the specified antibody products. No information regarding contract duration, period of performance, or future renewal terms has been provided in the available contract documentation.